Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Adolor aims to advance ADL-2-1294 into clinical trials

April 26, 1996

No Comments

BMS antimigraine agent poised to enter clinical trials

April 26, 1996

No Comments

NPC-18688 displays long-lasting antihyperalgesic effects in rodents

April 26, 1996

No Comments

SKB claims morphinoid derivatives

April 26, 1996

No Comments

OT-7100, Otsuka's new analgesic for peripheral pain

April 26, 1996

No Comments

Combined thrombolytic/neuroprotective agents more effective in treating stroke

April 19, 1996

No Comments

Nerve growth synthesis inducers produce neuroprotective effects

April 19, 1996

No Comments

SKB reports calcium antagonists for stroke

April 19, 1996

No Comments

New Takeda compounds suppress increased vascular permeability

April 19, 1996

No Comments

Lilly reports cannabinoid receptor antagonists

April 19, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Adolor aims to advance ADL-2-1294 into clinical trials

BMS antimigraine agent poised to enter clinical trials

NPC-18688 displays long-lasting antihyperalgesic effects in rodents

SKB claims morphinoid derivatives

OT-7100, Otsuka's new analgesic for peripheral pain

Combined thrombolytic/neuroprotective agents more effective in treating stroke

Nerve growth synthesis inducers produce neuroprotective effects

SKB reports calcium antagonists for stroke

New Takeda compounds suppress increased vascular permeability

Lilly reports cannabinoid receptor antagonists

Today's news in brief

Today's news in brief

Off-target immune response from modified mRNA impacts future development

‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s

Waging the losing battle: Altimmune takes on challengers as Pfizer falls back

Neurology/psychiatric RSS

Neurology/psychiatric
RSS